SAVING’ jab for severe asthma that could prevent deadly attacks with just two doses a year could be available to patients in the UK within months. Depemokimab – developed ...

Please provide your email address to receive an email when new articles are posted on . Depemokimab has high binding affinity and potency for IL-5. Eosinophils fell by 83% and 82% with treatment in ...

The American College of Chest Physicians (CHEST) recently released a new clinical guideline on biologic management in severe ...

GSK plc GSK announced that the FDA has approved Exdensur (depemokimab-ulaa), an ultra-long-acting IL-5–targeting biologic, as an add-on maintenance treatment of severe asthma with an eosinophilic ...

SaveHealth reports seven asthma medication categories, including inhaled corticosteroids and biologics, helping manage ...

Dr. Marc Cromie with the Chattanooga Allergy Clinic joins News 12’s Chip Chapman at the start of the New Year with some ...

A landmark study has shown that severe asthma can be controlled using biologic therapies, without the addition of regular high-dose inhaled steroids which can have significant side effects. The ...

Unlocking the Secrets of Severe Asthma: From Pathways to Precision is the launch of the brand new reelCE™ initiative, designed to educate U.S.-based pulmonologists, allergists, nurse practitioners, ...

What starts as breathlessness can turn fatal within minutes, doctors warn that quick action, correct inhaler use and timely medical help are the only lifesavers during a severe asthma attack.

GSK said Japan's Ministry of Health had approved its bronchial asthma treatment Exdensur after trial results showed ...

PARIS — Pregnancy is a period of asthma instability; it entails an increased risk for exacerbations. While therapeutic de-escalation, if not the outright cessation of maintenance treatment, is common, ...